FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295457304> ?p ?o ?g. }

• W4295457304 endingPage "e065001" @default.
• W4295457304 startingPage "e065001" @default.
• W4295457304 abstract "To investigate the eligibility of a real-world neovascular age-related macular degeneration (nAMD) population for the TENAYA and LUCERNE trials (testing faricimab), and to compare the eligible real-world patients to trial participants.In this retrospective cross-sectional study, we used data from the Swedish Macula Registry (SMR) between 1 January 2017 and 31 December 2020. Persons were eligible if they fulfilled the main inclusion criteria in TENAYA and LUCERNE: (1) nAMD diagnosis, (2) treatment naïve, (3) ≥50 years and (4) best-corrected visual acuity (BCVA) of 78-24 letters.Characteristics at the original visit of the eligible SMR population and baseline data from the clinical trials were compared.In total, 27 962 individuals with nAMD were registered in SMR. A total of 15 399 (55%) individuals were treatment naïve; of these, 15 368 (55%) were ≥50 years and 13 265 (47%) also had BCVA of 78-24 letters and fulfilled eligibility. Among treatment-naïve individuals, 86% were eligible and the BCVA criterion was the most common reason for non-eligibility. The eligible SMR population was significantly older than either TENAYA or LUCERNE. SMR included more women and patients with worse visual acuity than TENAYA, while SMR patients were diagnosed more quickly than LUCERNE.Almost half of the real-world nAMD population in SMR fulfilled the main inclusion criteria of the TENAYA and LUCERNE trials. Among treatment-naïve individuals, 86% were eligible. Marginally differences were shown between the eligible SMR population and the trial populations. The SMR population were older and more similar to the population in LUCERNE than TENAYA." @default.
• W4295457304 created "2022-09-14" @default.
• W4295457304 creator A5015179286 @default.
• W4295457304 creator A5022715739 @default.
• W4295457304 creator A5069959541 @default.
• W4295457304 date "2022-09-01" @default.
• W4295457304 modified "2023-09-25" @default.
• W4295457304 title "Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study" @default.
• W4295457304 cites W1786285359 @default.
• W4295457304 cites W187723863 @default.
• W4295457304 cites W1967981256 @default.
• W4295457304 cites W1996110610 @default.
• W4295457304 cites W2004395878 @default.
• W4295457304 cites W2017194458 @default.
• W4295457304 cites W2040664067 @default.
• W4295457304 cites W2077180817 @default.
• W4295457304 cites W2092501667 @default.
• W4295457304 cites W2101490359 @default.
• W4295457304 cites W2136940845 @default.
• W4295457304 cites W2169325394 @default.
• W4295457304 cites W2183781837 @default.
• W4295457304 cites W2462291236 @default.
• W4295457304 cites W2568773933 @default.
• W4295457304 cites W2579987799 @default.
• W4295457304 cites W2742297576 @default.
• W4295457304 cites W2747836769 @default.
• W4295457304 cites W2761604622 @default.
• W4295457304 cites W2770668652 @default.
• W4295457304 cites W2786459496 @default.
• W4295457304 cites W2789596123 @default.
• W4295457304 cites W2794284758 @default.
• W4295457304 cites W2809010234 @default.
• W4295457304 cites W2956665584 @default.
• W4295457304 cites W2975797570 @default.
• W4295457304 cites W3044951791 @default.
• W4295457304 cites W3047590017 @default.
• W4295457304 cites W3081461782 @default.
• W4295457304 cites W3095673714 @default.
• W4295457304 cites W3153918581 @default.
• W4295457304 cites W4200201460 @default.
• W4295457304 cites W4211020962 @default.
• W4295457304 cites W4220945173 @default.
• W4295457304 cites W4221012768 @default.
• W4295457304 cites W628894460 @default.
• W4295457304 doi "https://doi.org/10.1136/bmjopen-2022-065001" @default.
• W4295457304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36096541" @default.
• W4295457304 hasPublicationYear "2022" @default.
• W4295457304 type Work @default.
• W4295457304 citedByCount "1" @default.
• W4295457304 countsByYear W42954573042023 @default.
• W4295457304 crossrefType "journal-article" @default.
• W4295457304 hasAuthorship W4295457304A5015179286 @default.
• W4295457304 hasAuthorship W4295457304A5022715739 @default.
• W4295457304 hasAuthorship W4295457304A5069959541 @default.
• W4295457304 hasBestOaLocation W42954573041 @default.
• W4295457304 hasConcept C107130276 @default.
• W4295457304 hasConcept C118487528 @default.
• W4295457304 hasConcept C126322002 @default.
• W4295457304 hasConcept C142052008 @default.
• W4295457304 hasConcept C142724271 @default.
• W4295457304 hasConcept C187212893 @default.
• W4295457304 hasConcept C2776403814 @default.
• W4295457304 hasConcept C2778257484 @default.
• W4295457304 hasConcept C2908647359 @default.
• W4295457304 hasConcept C535046627 @default.
• W4295457304 hasConcept C71924100 @default.
• W4295457304 hasConcept C99454951 @default.
• W4295457304 hasConceptScore W4295457304C107130276 @default.
• W4295457304 hasConceptScore W4295457304C118487528 @default.
• W4295457304 hasConceptScore W4295457304C126322002 @default.
• W4295457304 hasConceptScore W4295457304C142052008 @default.
• W4295457304 hasConceptScore W4295457304C142724271 @default.
• W4295457304 hasConceptScore W4295457304C187212893 @default.
• W4295457304 hasConceptScore W4295457304C2776403814 @default.
• W4295457304 hasConceptScore W4295457304C2778257484 @default.
• W4295457304 hasConceptScore W4295457304C2908647359 @default.
• W4295457304 hasConceptScore W4295457304C535046627 @default.
• W4295457304 hasConceptScore W4295457304C71924100 @default.
• W4295457304 hasConceptScore W4295457304C99454951 @default.
• W4295457304 hasFunder F4320307779 @default.
• W4295457304 hasIssue "9" @default.
• W4295457304 hasLocation W42954573041 @default.
• W4295457304 hasLocation W42954573042 @default.
• W4295457304 hasLocation W42954573043 @default.
• W4295457304 hasLocation W42954573044 @default.
• W4295457304 hasLocation W42954573045 @default.
• W4295457304 hasOpenAccess W4295457304 @default.
• W4295457304 hasPrimaryLocation W42954573041 @default.
• W4295457304 hasRelatedWork W2088011133 @default.
• W4295457304 hasRelatedWork W2320987231 @default.
• W4295457304 hasRelatedWork W2332234963 @default.
• W4295457304 hasRelatedWork W2403423968 @default.
• W4295457304 hasRelatedWork W2601742736 @default.
• W4295457304 hasRelatedWork W2745923716 @default.
• W4295457304 hasRelatedWork W2889581307 @default.
• W4295457304 hasRelatedWork W2912568837 @default.
• W4295457304 hasRelatedWork W4281630725 @default.
• W4295457304 hasRelatedWork W2748529277 @default.

• next